EI
CSBR icon

EAM Investors’s Champions Oncology CSBR Stock Holding History

EAM Investors’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-79,987
Closed -$694K – 257
2025
Q1 		$694K Buy
+79,987
New +$810K 0.12% 193
2021
Q1 		– Sell
-99,763
Closed -$1.08M – 362
2020
Q4 		$1.08M Buy
+99,763
New +$1.03M 0.18% 258
2019
Q2 		– Sell
-46,892
Closed -$459K – 264
2019
Q1 		$459K Sell
46,892
-149,479
-76% -$1.49M 0.11% 242
2018
Q4 		$1.53M Buy
196,371
+16,398
+9% +$188K 0.42% 101
2018
Q3 		$3.14M Buy
+179,973
New +$1.6M 0.47% 100

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM Investors's CSBR Position: Q2 2025 in Review

EAM Investors sold out of Champions Oncology (CSBR) in Q2 2025, closing a stake of 79,987 shares — an estimated $694K sold.

EAM Investors first reported a position in CSBR in Q3 2018 and held it in 5 quarters. The position peaked at $3.14M in Q3 2018. 30 funds tracked by Wall St. Rank hold CSBR as of Q2 2025.

  • EAM Investors reported no remaining Champions Oncology position as of Q2 2025 after selling out during the quarter.
  • EAM Investors sold 79,987 Champions Oncology shares in Q2 2025, an estimated $694K.
  • EAM Investors first reported a position in Champions Oncology in Q3 2018 and held it in 5 quarters.
  • EAM Investors's Champions Oncology position peaked at $3.14M in Q3 2018.
  • 30 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2025.

Based on EAM Investors's 13F filing for Q2 2025, filed 12 Aug 2025.